Further studies have revealed that FAM225A interacts with miR-130a-5p to negatively regulate CNG1 expression, thereby inhibiting apoptosis and promoting sorafenib resistance of HCC cells (46). Here, FAM225A is linked to hepatocellular carcinoma.